100% Zufriedenheitsgarantie Sofort verfügbar nach Zahlung Sowohl online als auch als PDF Du bist an nichts gebunden
Vorher von dir gesucht
Test Bank Complete; Pharmacology and the Nursing Process 10th Edition, (2022) Lilley, Rainforth Collins & Snyder. All Chapters 1-58| Verified| Rationale9,89 €
In den Einkaufswagen
Test Bank Complete; Pharmacology and the Nursing Process 10th Edition, (2022) Lilley, Rainforth Collins & Snyder. All Chapters 1-58| Verified| Rationale
20 mal angesehen 0 mal verkauft
Kurs
Pharmacology and the Nursing Process 10th Edition
Hochschule
Pharmacology And The Nursing Process 10th Edition
Book
Pharmacology and the Nursing Process
Test Bank Complete; Pharmacology and the Nursing Process 10th Edition, (2022) Lilley, Rainforth Collins & Snyder. All Chapters 1-58| Verified| Rationale
TABLE OF CONTENTS
PART 1: PHARMACOLOGY BASICS 5
Chapter 01: The Nursing Process And Drug Therapy 5
Chapter 02: Pharmacologic Principles 11
...
Test Bank - Pharmacology and the Nursing Procss, 10th Edition ( Lilley, 2022) ,Latest Edition|| All Chapters
Test Bank for Pharmacology and the Nursing Process, 10th edition by Lilley, Collins & Snyder All 1-58 Chapters Covered ,Latest Edition, ISBN:9780323827973
Test Bank for Pharmacology and the Nursing Process 10th Edition By Linda Lilley, Shelly Collins, Julie Snyder | 9780323827973 |Chapter 1-58 ISBN: 9780323827973 All Chapters Fully Covered with Answers ...
Alles für dieses Buch (100)
Schule, Studium & Fach
Pharmacology and the Nursing Process 10th Edition
Pharmacology and the Nursing Process 10th Edition
Verkäufer
Folgen
Bestmaxsolutions
Deine Reviews
Inhaltsvorschau
Test Bank Complete_
Pharmacology and the Nursing Process 10th Edition, (2022)
Linda Lane Lilley (Author), Shelly Rainforth Collins (Author),
Julie S. Snyder (Author) All Chapters 1-58| Verified| Rationale
10TH EDITION
, TABLE OF CONTENTS
PART 1: PHARMACOLOGY BASICS ______________________________________________ 5
Chapter 01: The Nursing Process And Drug Therapy ___________________________________ 5
Chapter 02: Pharmacologic Principles ______________________________________________ 11
Chapter 03: Lifespan Considerations _______________________________________________ 20
Chapter 04: Cultural, Legal, And Ethical Considerations ________________________________ 29
Chapter 05: Medication Errors: Preventing And Responding ____________________________ 37
Chapter 06: Patient Education And Drug Therapy ____________________________________ 42
Chapter 07: Over-The-Counter Drugs And Herbal And Dietary Supplements _______________ 48
Chapter 08: Gene Therapy And Pharmacogenomics __________________________________ 54
Chapter 09: Photo Atlas Of Drug Administration _____________________________________ 60
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM _______________________ 72
Chapter 10: Analgesic Drugs _____________________________________________________ 72
Chapter 11: General And Local Anesthetics _________________________________________ 81
Chapter 12: Central Nervous System Depressants And Muscle Relaxants _________________ 86
Chapter 13: Central Nervous System Stimulants And Related Drugs _____________________ 93
Chapter 14: Antiepileptic Drugs ___________________________________________________ 98
Chapter 15: Antiparkinson Drugs_________________________________________________ 105
Chapter 16: Psychotherapeutic Drugs _____________________________________________ 112
Chapter 17: Substance Use Disorder ______________________________________________ 122
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM __________________ 129
Chapter 18: Adrenergic Drugs ___________________________________________________ 129
Chapter 19: Adrenergic-Blocking Drugs____________________________________________ 135
Chapter 20: Cholinergic Drugs ___________________________________________________ 142
Chapter 21: Cholinergic-Blocking Drugs ___________________________________________ 149
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ___________ 156
Chapter 22: Antihypertensive Drugs ______________________________________________ 156
Chapter 23: Antianginal Drugs ___________________________________________________ 164
Chapter 24: Heart Failure Drugs _________________________________________________ 172
Chapter 25: Antidysrhythmic Drugs ______________________________________________ 179
, Chapter 26: Coagulation Modifier Drugs ___________________________________________ 186
Chapter 27: Antilipemic Drugs ___________________________________________________ 194
Chapter 28: Diuretic Drugs ______________________________________________________ 201
Chapter 29: Fluids And Electrolytes _______________________________________________ 209
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS _________ 217
Chapter 30: Pituitary Drugs _____________________________________________________ 217
Chapter 31: Thyroid And Antithyroid Drugs ________________________________________ 222
Chapter 32: Antidiabetic Drugs __________________________________________________ 229
Chapter 33: Adrenal Drugs ______________________________________________________ 241
Chapter 34: Women’s Health Drugs ______________________________________________ 247
Chapter 35: Men’s Health Drugs _________________________________________________ 256
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM __________________________ 262
Chapter 36: Antihistamines, Decongestants, Antitussives, And Expectorants _____________ 262
Chapter 37: Respiratory Drugs ___________________________________________________ 269
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS _______________________ 277
Chapter 38: Antibiotics Part 1 ___________________________________________________ 277
Chapter 39: Antibiotics Part 2 ___________________________________________________ 286
Chapter 40: Antiviral Drugs _____________________________________________________ 293
Chapter 41: Antitubercular Drugs ________________________________________________ 300
Chapter 42: Antifungal Drugs____________________________________________________ 307
Chapter 43: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ______________________ 314
Chapter 44: Anti-Inflammatory And Antigout Drugs _________________________________ 320
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS ______ 327
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle-Specific Drugs ____ 327
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs And Miscellaneous Drugs
___________________________________________________________________________ 335
Chapter 47: Biologic Response–Modifying And Antirheumatic Drugs ____________________ 341
Chapter 48: Immunosuppressant Drugs ___________________________________________ 347
Chapter 49: Immunizing Drugs __________________________________________________ 354
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION _______ 360
Chapter 50: Acid-Controlling Drugs _______________________________________________ 360
Chapter 51: Bowel Disorder Drugs _______________________________________________ 368
Chapter 52: Antiemetic And Antinausea Drugs _____________________________________ 378
Chapter 53: Vitamins And Minerals _______________________________________________ 385
,PART 1: PHARMACOLOGY BASICS
Chapter 01: The Nursing Process And Drug Therapy
Linda Lilley: Pharmacology and the Nursing Process 10th Edition, (2022) Test Bank
MULTIPLE CHOICE
1. The Nurse Is Developing A Human Needs Statement For A Patient Who Has A New
Diagnosis Of Heart Failure. Identification Of Human Needs Statements Occur With
Which Of These Activities?
A. Collection Of Patient Data
B. Administering Interventions
C. Deciding On Patient Outcomes
D. Documenting The Patient’s Behavior
CORRECT ANS: A
Identification Of Human Needs Occurs With The Collection Of Patient Data.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Human Needs Statement
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
2. The Patient Is To Receive Oral Guaifenesin (Mucinex) Twice A Day. Today, The
Nurse Was Busy And Gave The Medication 2 Hours After The Scheduled Dose Was
Due. What Type Of Problem Does This Represent?
A. “Right Time”
B. “Right Dose”
C. “Right Route”
D. “Right Medication”
CORRECT ANS: A
,“Right Time” Is Correct Because The Medication Was Given More Than 30 Minutes
After The Scheduled Dose Was Due. “Dose” Is Incorrect Because The Dose Is Not
Related To The Time The Medication Administration Is Scheduled. “Route” Is
Incorrect Because The Route Is Not Affected. “Medication” Is Incorrect Because The
Medication Ordered Will Not Change.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Safety And Infection Control
3. The Nurse Has Been Monitoring The Patient’s Progress On A New Drug Regimen
Since The First Dose And Documenting The Patient’s Therapeutic Response To The
Medication. Which Phase Of The Nursing Process Do These Actions Illustrate?
A. Human Needs Statement
B. Planning
C. Implementation
D. Evaluation
CORRECT ANS: D
Monitoring The Patient’s Progress, Including The Patient’s Response To The
Medication, Is Part Of The Evaluation Phase. Planning, Implementation, And Human
Needs Statement Are Not Illustrated By This Example.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Evaluation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
4. The Nurse Is Assigned To A Patient Who Is Newly Diagnosed With Type 1 Diabetes
Mellitus. Which Statement Best Illustrates An Outcome Criterion For This Patient?
A. The Patient Will Follow Instructions.
B. The Patient Will Not Experience Complications.
C. The Patient Will Adhere To The New Insulin Treatment Regimen.
,D. The Patient Will Demonstrate Correct Blood Glucose Testing Technique.
CORRECT ANS: D
“Demonstrating Correct Blood Glucose Testing Technique” Is A Specific And
Measurable Outcome Criterion. “Following Instructions” And “Not Experiencing
Complications” Are Not Specific Criteria. “Adhering To New Regimen” Would Be
Difficult To Measure.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process: Planning
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
5. Which Activity Best Reflects The Implementation Phase Of The Nursing Process For
The Patient Who Is Newly Diagnosed With Hypertension?
A. Providing Education On Keeping A Journal Of Blood Pressure Readings
B. Setting Goals And Outcome Criteria With The Patient’s Input
C. Recording A Drug History Regarding Over-The-Counter Medications Used At
Home
D. Formulating Human Needs Statements Regarding Insufficient Knowledge Related
To The New Treatment Regimen
CORRECT ANS: A
Education Is An Intervention That Occurs During The Implementation Phase. Setting
Goals And Outcomes Reflects The Planning Phase. Recording A Drug History
Reflects The Assessment Phase. Formulating Human Needs Statements Reflects
Analysis Of Data As Part Of Planning.
DIF: Cognitive Level: Applying (Application) TOP: Nursing Process:
Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
6. The Medication Order Reads, “Give Ondansetron (Zofran) 4 Mg, 30 Minutes Before
Beginning Chemotherapy To Prevent Nausea.” The Nurse Notes That The Route Is
Missing From The Order. What Is The Nurse’s Best Action?
, A. Give The Medication Intravenously Because The Patient Might Vomit.
B. Give The Medication Orally Because The Tablets Are Available In 4-Mg Doses.
C. Contact The Prescriber To Clarify The Route Of The Medication Ordered.
D. Hold The Medication Until The Prescriber Returns To Make Rounds.
CORRECT ANS: C
A Complete Medication Order Includes The Route Of Administration. If A
Medication Order Does Not Include The Route, The Nurse Must Ask The Prescriber
To Clarify It. The Intravenous And Oral Routes Are Not Interchangeable. Holding
The Medication Until The Prescriber Returns Would Mean That The Patient Would
Not Receive A Needed Medication.
DIF: Cognitive Level: Applying (Application)
TOP: Nursing Process: Implementation
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
7. When The Nurse Considers The Timing Of A Drug Dose, Which Factor Is
Appropriate To Consider When Deciding When To Give A Drug?
A. The Patient’s Ability To Swallow
B. The Patient’s Height
C. The Patient’s Last Meal
D. The Patient’s Allergies
CORRECT ANS: C
The Nurse Must Consider Specific Pharmacokinetic/Pharmacodynamic Drug
Properties That May Be Affected By The Timing Of The Last Meal. The Patient’s
Ability To Swallow, Height, And Allergies Are Not Factors To Consider Regarding
The Timing Of The Drug’s Administration.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Assessment
MSC: NCLEX: Safe And Effective Care Environment: Management Of Care
Alle Vorteile der Zusammenfassungen von Stuvia auf einen Blick:
Garantiert gute Qualität durch Reviews
Stuvia Verkäufer haben mehr als 700.000 Zusammenfassungen beurteilt. Deshalb weißt du dass du das beste Dokument kaufst.
Schnell und einfach kaufen
Man bezahlt schnell und einfach mit iDeal, Kreditkarte oder Stuvia-Kredit für die Zusammenfassungen. Man braucht keine Mitgliedschaft.
Konzentration auf den Kern der Sache
Deine Mitstudenten schreiben die Zusammenfassungen. Deshalb enthalten die Zusammenfassungen immer aktuelle, zuverlässige und up-to-date Informationen. Damit kommst du schnell zum Kern der Sache.
Häufig gestellte Fragen
Was bekomme ich, wenn ich dieses Dokument kaufe?
Du erhältst eine PDF-Datei, die sofort nach dem Kauf verfügbar ist. Das gekaufte Dokument ist jederzeit, überall und unbegrenzt über dein Profil zugänglich.
Zufriedenheitsgarantie: Wie funktioniert das?
Unsere Zufriedenheitsgarantie sorgt dafür, dass du immer eine Lernunterlage findest, die zu dir passt. Du füllst ein Formular aus und unser Kundendienstteam kümmert sich um den Rest.
Wem kaufe ich diese Zusammenfassung ab?
Stuvia ist ein Marktplatz, du kaufst dieses Dokument also nicht von uns, sondern vom Verkäufer Bestmaxsolutions. Stuvia erleichtert die Zahlung an den Verkäufer.
Werde ich an ein Abonnement gebunden sein?
Nein, du kaufst diese Zusammenfassung nur für 9,89 €. Du bist nach deinem Kauf an nichts gebunden.
